Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.18
-0.05-4.07%
IN8bio Inc (INAB) Stock Price, Quote, News & History
INABNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases....
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of IN8bio (NASDAQ:INAB) through any online brokerage.
Other companies in IN8bio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
IN8bio has a consensus price target of $104.25.
The stock price for IN8bio (NASDAQ: INAB) is $1.18 last updated .
There are no upcoming dividends for IN8bio.
IN8bio does not have any upcoming earnings scheduled.
There is no upcoming split for IN8bio.
IN8bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
